MANHATTAN SCIENTIFICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Manhattan Scientifics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2011 to Q2 2024.
  • Manhattan Scientifics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$158K, a 31% increase year-over-year.
  • Manhattan Scientifics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$1.06M, a 5.38% increase year-over-year.
  • Manhattan Scientifics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$1.17M, a 57.3% increase from 2022.
  • Manhattan Scientifics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$2.73M, a 25% increase from 2021.
  • Manhattan Scientifics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$3.64M, a 184% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.06M -$158K +$71K +31% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$1.13M -$382K +$38K +9.05% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-19
Q4 2023 -$1.17M -$254K +$142K +35.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-02
Q3 2023 -$1.31M -$262K -$191K -269% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$1.12M -$229K +$1.39M +85.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$2.5M -$420K +$227K +35.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-19
Q4 2022 -$2.73M -$396K -$362K -1065% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-02
Q3 2022 -$2.37M -$71K +$1.09M +93.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$3.45M -$1.62M +$967K +37.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$4.42M -$647K -$781K -583% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$3.64M -$34K -$2.79M -101% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-13
Q3 2021 -$848K -$1.16M -$2.92M -166% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.07M -$2.58M -$3.11M -589% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 $5.18M $134K +$866K Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 $4.31M $2.76M +$3.86M Oct 1, 2020 Dec 31, 2020 10-K 2022-04-06
Q3 2020 $450K $1.76M +$532K +43.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$82K $528K +$1.44M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$1.52M -$732K -$296K -67.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$1.22M -$1.11M +$2.51M +69.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$3.73M $1.23M +$905K +279% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$4.64M -$908K +$1.31M +59% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$5.94M -$436K +$2.39M +84.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$8.33M -$3.62M -$836K -30.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$7.5M $324K +$3.86M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$11.4M -$2.21M -$11.3M -124% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 -$100K -$2.83M -$1.65M -139% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 $1.55M -$2.78M -$2.01M -262% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $3.56M -$3.54M -$2.18M -161% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q2 2017 $5.74M $9.05M +$11.1M Apr 1, 2017 Jun 30, 2017 10-Q/A 2018-08-28
Q1 2017 -$5.39M -$1.18M +$714K +37.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$6.11M -$768K +$647K +45.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$6.76M -$1.35M +$735K +35.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$7.49M -$2.09M -$82K -4.08% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-18
Q1 2016 -$7.41M -$1.9M -$15.4M -114% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $8.01M -$1.42M -$552K -64% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 $8.56M -$2.09M -$1.32M -173% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 $9.89M -$2.01M -$956K -90.8% Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-22
Q1 2015 $10.8M $13.5M +$14.6M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-18
Q4 2014 -$3.81M -$863K -$2.33M -159% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$1.47M -$764K +$2.13M +73.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-19
Q2 2014 -$3.6M -$1.05M -$487K -86% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$3.12M -$1.13M -$1.19M -1915% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-19
Q4 2013 -$1.93M $1.47M +$1.95M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$3.88M -$2.89M -$2.57M -793% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$1.31M -$566K +$123K +17.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$1.43M $62K +$656K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$2.09M -$483K +$126K +20.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-01
Q3 2012 -$2.22M -$324K +$741K +69.6% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-13
Q2 2012 -$2.96M -$689K -$376K -120% Apr 1, 2012 Jun 30, 2012 10-Q/A 2012-09-13
Q1 2012 -$2.58M -$594K -$294K -98% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$2.29M -$609K Oct 1, 2011 Dec 31, 2011 10-K/A 2013-04-08
Q3 2011 -$1.07M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$313K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-13
Q1 2011 -$300K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.